FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093586 [Registered on: 25/08/2025] Trial Registered Prospectively
Last Modified On: 25/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative study of postoperative nausea and vomiting in patients undergoing laparoscopic removal of gall bladder using narcotic pain killer versus non narcotic pain killer. 
Scientific Title of Study   Comparative randomised controlled study of PONV(postoperative nausea and vomiting) in laparoscopic cholecystectomy, opioid vs ketamine lignocaine based anesthesia 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Haneefa Khan 
Designation  Resident 
Affiliation  Peerless Hospital & B K Roy Research Centre 
Address  Peerless Hospital & B K Roy Research Centre, 360, Panchasayar,Kolkata.

Kolkata
WEST BENGAL
700094
India 
Phone  7981771458  
Fax    
Email  haneefa1khan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Avijit Banerjee 
Designation  Senior Consultant Anaesthesiologist 
Affiliation  Peerless Hospital & B K Roy Research Centre 
Address  Peerless Hospital & B K Roy Research Centre, 360, Panchasayar, Kolkata.

Kolkata
WEST BENGAL
700094
India 
Phone  6289508707  
Fax    
Email  draviban@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Avijit Banerjee 
Designation  Senior Consultant Anaesthesiologist 
Affiliation  Peerless Hospital & B K Roy Research Centre 
Address  Peerless Hospital & B K Roy Research Centre, 360, Panchasayar ,Kolkata.

Kolkata
WEST BENGAL
700094
India 
Phone  6289508707  
Fax    
Email  draviban@gmail.com  
 
Source of Monetary or Material Support  
Peerless Hospital & B K Roy Research Centre, 360, Panchasayar, Kolkata, 700094.  
 
Primary Sponsor  
Name  Dr Haneefa Khan 
Address  Peerless Hospital & B K Roy Research Centre, 360, Panchasayar,Kolkata.  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Haneefa Khan  Peerless Hospital & B K Roy Research Centre  Department of anaesthesiology, Main OT Complex, General Surgery, OT Room number 4, 3rd floor, Peerless Hospital & B K Roy Research Centre, 360, Panchasayar, Kolkata, 700094.
Kolkata
WEST BENGAL 
7981771458

haneefa1khan@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Clinical Research Ethics Committee Peerless Hospitex Hospital And Research Center Ltd  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K80||Cholelithiasis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Lignocaine and Ketamine   lignocaine (loading dose with 2 mg/kg followed by 1.5 mg/kg/hr continuous infusion) and a single dose of ketamine 0.4 mg/kg given 5 minutes before estimated extubation time .  
Comparator Agent  Morphine   morphine 0.2 mg/kg.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1) The patients who have given informed consent.
2) The Patients of ASA-American Society of Anaesthesiologists Grade I, II.
3) The Patients aged 18 -50yrs.
4) The patients who are electively scheduled for laproscopic cholecystectomy.

 
 
ExclusionCriteria 
Details  1) The patients who refused to participate in the study.
2) The patients with ASA Grade 3 and above.
3) Patients aged below 18 and above 50 years.
4) Vestibular disorders, pregnancy and patients with history of chemotherapy.
5) The patients with known hypersensitivity to the local anaesthetics & Opioids.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduced incidence of PONV(post operative nausea & vomiting) in laproscopic cholecystectomy patients without compromising on intraoperative haemodynamic stability of patient.
 
24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Prevention Of Opioid Related Adverse Effects
 
24 hours 
Early Recovery After Surgery
 
24 hours 
Patients Comfort During Perioperative Period
 
24 hours 
Patients Satisfaction During Perioperative Period.
 
24 hours 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  Self e-mail (haneefa1khan@gmail.com)

  6. For how long will this data be available start date provided 30-05-2025 and end date provided 15-12-2031?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
  • Postoperative nausea and vomiting (PONV) is defined as any nausea, retching, or vomiting occurring during the first 24 hours after surgery.
  • PONV is one of the most common causes of patient dissatisfaction and unanticipated hospital admission after anaesthesia, with reported incidences of 40% in patients who undergo general anaesthesia and can be  up to 80% in high-risk patients.
  • The  highest risk patients for PONV appear to be young to middle-aged, non-smoking females with a history of PONV or motion sickness (all are independent risk factors).
  • It could result in many adverse events such as discomfort, dehiscence of sutures, increased bleeding, esophageal rupture (Boerhaave’s Syndrome), incisional hernia, raised ICP, dehydration if prolonged, metabolic alkalosis with loss of hydrogen, chloride, potassium, sodium and water, gastric content aspiration, pneumonia and esophageal rupture and result in delayed discharge from the hospital.Increased medical costs, and hospital readmission are all common in cases of PONV.
  • As the need for ambulatory surgery increases, the prevention of PONV continues to become more important to the system based approach of anesthesiology
  • Our aim is to reduce the incidence of PONV in patients undergoing laproscopic cholecystectomy using opioid versus using lignocaine and ketamine during anaesthesia.
  • This is a single institutional Prospective randomised control trial involving 100 patients who underwent laparoscopic cholecystectomy for a period of 15 months from September 2025 to December 2026 in Peerless Hospital And B K Roy Research Centre, Kolkata.
 
Close